{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:04:43Z","timestamp":1769043883227,"version":"3.49.0"},"reference-count":57,"publisher":"Oceanside Publications Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Anaphylaxis is an acute life-threatening event that requires emergent diagnosis and treatment. However, focus on prevention of anaphylaxis is essential in reducing anaphylaxis recurrences and associated mortality.  <jats:bold>Objective:<\/jats:bold> This literature\n review was aimed to be a comprehensive resource for practicing allergists in managing anaphylaxis in the long term. We discussed the role of the allergist in the long-term outpatient management of anaphylaxis through identifying risk factors, allergen avoidance, prevention of recurrences,\n and patient education.  <jats:bold>Methods:<\/jats:bold> A medical literature search that focused on several areas of long-term management of anaphylaxis was conducted.  <jats:bold>Results:<\/jats:bold> Patients evaluated by an allergist are more likely to have their anaphylaxis trigger identified,\n to have their underlying mast cell disorder diagnosed, and to receive desensitization or allergen immunotherapy. Allergists can prevent fatal anaphylaxis by preventing and treating anaphylaxis in patients with ischemic heart disease and by optimally treating patients with comorbid asthma.\n Allergists can offer specific prevention strategies for allergenic trigger and cofactor avoidance. Education should be focused on patients with a higher risk for recurrence of anaphylaxis, such as those patients with a history of severe symptoms or anaphylaxis, with a peanut and\/or tree nut\n trigger, or with a history of asthma, or female gender. Patient counseling involves providing individualized action plans at each visit and discussing proper use, storage, and safety of epinephrine autoinjectors. Multiple doses of epinephrine need to be prescribed to those who are at risk\n for severe food-induced, venom immunotherapy\u2010related, or venom-induced anaphylaxis. Wording on medical identification products should be reviewed by the allergist. Anaphylaxis resources for health-care providers are summarized in the article.  <jats:bold>Conclusion:<\/jats:bold> Ongoing\n education, providing personalized anaphylaxis action plans, reducing risk factors, and avoiding triggers are key to anaphylaxis prevention and long-term management.<\/jats:p>","DOI":"10.2500\/aap.2023.44.220089","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T04:46:31Z","timestamp":1672202791000},"page":"35-44","source":"Crossref","is-referenced-by-count":7,"title":["Anaphylaxis: Long-term management and resources"],"prefix":"10.2500","volume":"44","author":[{"given":"Aishwarya","family":"Navalpakam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narin","family":"Thanaputkaiporn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavadee","family":"Poowuttikul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2021.01.003","article-title":"Severity grading system for acute allergic reactions: a multidisciplinary Delphi study","volume":"148","author":"Dribin","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jaip.2014.07.011","article-title":"Outcomes of allergy\/immunology follow-up after an emergency department evaluation for anaphylaxis","volume":"3","author":"Campbell","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2500\/aap.2022.43.210106","article-title":"Prognosis of food-induced anaphylaxis in children: a single-center real-life study","volume":"43","author":"Buyuk Yaytokgil","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.anai.2015.07.019","article-title":"Anaphylaxis\u2013a practice parameter update 2015","volume":"115","author":"Lieberman","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jaci.2005.12.002","article-title":"Anaphylaxis, killer allergy: long-term management in the community","volume":"117","author":"Simons","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.10.029","article-title":"Case fatality and population mortality associated with anaphylaxis in the United States","volume":"133","author":"Ma","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJM199208063270603","article-title":"Fatal and near-fatal anaphylactic reactions to food in children and adolescents","volume":"327","author":"Sampson","year":"1992","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1081-1206(10)60714-4","article-title":"Fatal anaphylaxis: postmortem findings and associated comorbid diseases","volume":"98","author":"Greenberger","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1067\/mai.2001.112031","article-title":"Fatalities due to anaphylactic reactions to foods","volume":"107","author":"Bock","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.all.0000136762.89313.0b","article-title":"Anaphylaxis: can we tell who is at risk of a fatal reaction?","volume":"4","author":"Pumphrey","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/ACI.0b013e328259c328","article-title":"Cardiovascular disease and anaphylaxis","volume":"7","author":"Mueller","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2500\/aap.2021.42.210031","article-title":"Emergency department revisits and rehospitalizations among infants and toddlers for acute allergic reactions","volume":"42","author":"Robinson","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1046\/j.1365-2222.2000.00864.x","article-title":"Lessons for management of anaphylaxis from a study of fatal reactions","volume":"30","author":"Pumphrey","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"B14","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B15","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1365-2222.2003.01671.x","article-title":"Anaphylaxis: risk factors for recurrence","volume":"33","author":"Mullins","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"B16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.anai.2018.08.021","article-title":"Risk factors for recurrent anaphylaxis-related emergency department visits in the United States","volume":"121","author":"Motosue","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B17","year":"2004"},{"key":"B18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/pai.13244","article-title":"Can my child with IgE-mediated peanut allergy introduce foods labeled with \"may contain traces\"?","volume":"31","author":"Graham","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"B19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2016.01.001","article-title":"Food allergen immunotherapy: current status and prospects for the future","volume":"137","author":"Wood","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.anai.2016.10.031","article-title":"Stinging insect hypersensitivity: a practice parameter update 2016","volume":"118","author":"Golden","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.iac.2016.08.017","article-title":"Mastocytosis and anaphylaxis","volume":"37","author":"Schuch","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"B22","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.jaci.2009.10.028","article-title":"Drug allergy","volume":"125","author":"Khan","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaip.2013.11.007","article-title":"Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children","volume":"2","author":"Hong","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2500\/aap.2021.42.210081","article-title":"Idiopathic anaphylaxis: diagnosis and management","volume":"42","author":"Burrows","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaip.2019.09.017","article-title":"Diagnosis and management of patients with the alpha-gal syndrome","volume":"8","author":"Platts-Mills","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"B27","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.2500\/aap.2021.42.210007","article-title":"Evaluation of anaphylaxis recurrence and adrenaline autoinjector use in childhood","volume":"42","author":"Turgay Yagmur","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B28","article-title":"Create an allergy and anaphylaxis emergency plan: AAP Report Explained","author":"Pistiner"},{"key":"B29","article-title":"Food allergy and anaphylaxis emergency care plan 2021"},{"key":"B30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/anae.13958","article-title":"Medical identification or alert jewelry: an opportunity to save lives or an unreliable hindrance?","volume":"72","author":"Rahman","year":"2017","journal-title":"Anaesthesia"},{"key":"B31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaip.2012.11.004","article-title":"Prospective evaluation of an anaphylaxis education mini-handout: the AAAAI anaphylaxis wallet card","volume":"1","author":"Hernandez-Trujillo","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2500\/aap.2021.42.200099","article-title":"Epinephrine autoinjector prescription filling after pediatric emergency department discharge","volume":"42","author":"Cohen","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B33","first-page":"837","article-title":"First-aid treatment of anaphylaxis to food: focus on epinephrine","volume":"113","author":"Simons","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"B34","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/all.12595","article-title":"Excess subcutaneous tissue may preclude intramuscular delivery when using adrenaline autoinjectors in patients with anaphylaxis","volume":"70","author":"Johnstone","year":"2015","journal-title":"Allergy"},{"key":"B35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2500\/aap.2021.42.200108","article-title":"Ideal body position for epinephrine autoinjector administration","volume":"42","author":"Wang","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B36","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jaci.2012.08.029","article-title":"Obesity is not a risk factor for repeat epinephrine use in the treatment of anaphylaxis","volume":"130","author":"Rudders","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1067\/mai.2002.120758","article-title":"EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis","volume":"109","author":"Simons","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"B38","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/ACI.0b013e32833bc670","article-title":"Epinephrine and its use in anaphylaxis: current issues","volume":"10","author":"Simons","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaci.2008.04.031","article-title":"Use of multiple doses of epinephrine in food-induced anaphylaxis in children","volume":"122","author":"Jarvinen","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B40","first-page":"1","article-title":"Trauma, the scourge of modern society","volume":"75","author":"Knottenbelt","year":"1989","journal-title":"S Afr Med J"},{"key":"B41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.anai.2019.06.005","article-title":"Usability and preference of epinephrine auto-injectors: Auvi-Q and EpiPen Jr","volume":"123","author":"Kessler","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B42","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1067\/mai.2001.119916","article-title":"Epinephrine for the out-of-hospital (first-aid) treatment of anaphylaxis in infants: is the ampule\/syringe\/needle method practical?","volume":"108","author":"Simons","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"B43","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaip.2016.12.018","article-title":"The high cost of epinephrine autoinjectors and possible alternatives","volume":"5","author":"Pepper","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1081-1206(10)60332-8","article-title":"Hazards of unintentional injection of epinephrine from autoinjectors: a systematic review","volume":"102","author":"Simons","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.annemergmed.2015.07.011","article-title":"Lacerations and embedded needles caused by epinephrine autoinjector use in children","volume":"67","author":"Brown","year":"2016","journal-title":"Ann Emerg Med"},{"key":"B46","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1067\/mai.2000.106042","article-title":"Outdated EpiPen and EpiPen Jr autoinjectors: past their prime?","volume":"105","author":"Simons","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"B47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anai.2016.04.006","article-title":"A systematic review of epinephrine degradation with exposure to excessive heat or cold","volume":"117","author":"Parish","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.anai.2015.01.015","article-title":"Epinephrine doses contained in outdated epinephrine auto-injectors collected in a Florida allergy practice","volume":"114","author":"Rachid","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B49","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000341367","article-title":"A real-life study on acquired skills from using an adrenaline autoinjector","volume":"160","author":"Topal","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"B50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaci.2012.04.003","article-title":"Adverse reactions to vaccines practice parameter 2012 update","volume":"130","author":"Kelso","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B51","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1051\/medsci\/2010268-9719","article-title":"Drugs as risk factors of food anaphylaxis in adults","volume":"26","author":"Moneret-Vautrin","year":"2010","journal-title":"Med Sci (Paris)"},{"key":"B52","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0091-6749(03)01940-7","article-title":"Life-threatening anaphylaxis to venom immunotherapy in a patient taking an angiotensin-converting enzyme inhibitor","volume":"112","author":"Ober","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40413-015-0081-0","article-title":"Risk multipliers for severe food anaphylaxis","volume":"8","author":"Smith","year":"2015","journal-title":"World Allergy Organ J"},{"key":"B54","first-page":"929","article-title":"Beta-blocker therapy and the risk of anaphylaxis","volume":"136","author":"Toogood","year":"1987","journal-title":"CMAJ"},{"key":"B55","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jaci.2004.02.043","article-title":"Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis","volume":"113","author":"TenBrook","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"B56","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00000542-198109000-00028","article-title":"Hemodynamics, plasma histamine, and catecholamine concentrations during an anaphylactoid reaction to morphine","volume":"55","author":"Fahmy","year":"1981","journal-title":"Anesthesiology"},{"key":"B57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.anai.2013.06.001","article-title":"Heterogeneity in presentation and treatment of catamenial anaphylaxis","volume":"111","author":"Bauer","year":"2013","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2023\/00000044\/00000001\/art00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T16:39:31Z","timestamp":1675183171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2023.44.220089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,1]]}},"alternative-id":["1088-5412(20230101)44:1L.35;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2023.44.220089","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,1]]}}}